C. Ewel

531 total citations
18 papers, 436 citations indexed

About

C. Ewel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, C. Ewel has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in C. Ewel's work include Immune Cell Function and Interaction (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Acute Myeloid Leukemia Research (2 papers). C. Ewel is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Acute Myeloid Leukemia Research (2 papers). C. Ewel collaborates with scholars based in United States, South Africa and United Kingdom. C. Ewel's co-authors include Joseph A. Bellanti, Douglas O. Sobel, Barbara J. Zeligs, Marie L. Foegh, John W. Smith, Walter J. Urba, James E. Talmadge, Ronald G. Steis, Val Abbassi and Jeffrey L. Rossio and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Diabetes and Immunological Reviews.

In The Last Decade

C. Ewel

18 papers receiving 415 citations

Peers

C. Ewel
C. Ewel
Citations per year, relative to C. Ewel C. Ewel (= 1×) peers Fabrizio Scatena

Countries citing papers authored by C. Ewel

Since Specialization
Citations

This map shows the geographic impact of C. Ewel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ewel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ewel more than expected).

Fields of papers citing papers by C. Ewel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ewel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ewel. The network helps show where C. Ewel may publish in the future.

Co-authorship network of co-authors of C. Ewel

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ewel. A scholar is included among the top collaborators of C. Ewel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ewel. C. Ewel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gong, Jason, Christine L. Baker, Kelly H. Zou, et al.. (2016). A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation. Journal of Managed Care & Specialty Pharmacy. 22(12). 1417–1425. 19 indexed citations
2.
Jackson, John D., Elif Özerol, Yun Yan, C. Ewel, & James E. Talmadge. (2000). Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on Human Hematopoietic Progenitor Cells in Short-Term and Long-Term Bone Marrow Cultures. Journal of Hematotherapy & Stem Cell Research. 9(4). 489–496. 8 indexed citations
3.
Deeg, H. Joachim, Kristy Seidel, David S. Hong, et al.. (1997). In vivo radioprotective effect of AcSDKP on canine myelopoiesis. Annals of Hematology. 74(3). 117–122. 10 indexed citations
4.
Watanabe, Tsutomu, Linda Kelsey, Yun Yan, et al.. (1996). In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte‐colony stimulating factor following sublethal irradiation. British Journal of Haematology. 94(4). 619–627. 12 indexed citations
5.
Witt, Patricia L., et al.. (1996). Phase I/IB Study of Polyadenylic-Polyuridylic Acid in Patients with Advanced Malignancies: Clinical and Biologic Effects. Journal of Interferon & Cytokine Research. 16(8). 631–635. 4 indexed citations
6.
Yan, Yun, et al.. (1996). Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.. PubMed. 24(3). 475–81. 27 indexed citations
7.
Watanabe, Tsutomu, Yun Yan, J.D. Jackson, et al.. (1996). In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.. PubMed. 24(6). 713–21. 22 indexed citations
8.
Holmlund, Jon, William C. Kopp, Robert H. Wiltrout, et al.. (1995). A Phase I Clinical Trial of Flavone-8-Acetic Acid in Combination With Interleukin 2. JNCI Journal of the National Cancer Institute. 87(2). 134–136. 4 indexed citations
9.
Hong, Daesik, T. Graham, C. Ewel, Rainer Storb, & H. Joachim Deeg. (1995). Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.. PubMed. 23(7). 639–44. 7 indexed citations
10.
Sobel, Douglas O., C. Ewel, Barbara J. Zeligs, et al.. (1994). Poly I:C Induction of α-Interferon in the Diabetes-Prone BB and Normal Wistar Rats: Dose-Response Relationships. Diabetes. 43(4). 518–522. 25 indexed citations
11.
Ewel, C. & Marie L. Foegh. (1993). Chronic Graft Rejection: Accelerated Transplant Arteriosclerosis. Immunological Reviews. 134(1). 21–31. 30 indexed citations
12.
Kopp, William C., John W. Smith, C. Ewel, et al.. (1993). Immunomodulatory Effects of Interferon-?? in Patients with Metastatic Malignant Melanoma. Journal of Immunotherapy. 13(3). 181–190. 20 indexed citations
13.
Ewel, C., Walter J. Urba, William C. Kopp, et al.. (1992). Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.. PubMed. 52(11). 3005–10. 45 indexed citations
14.
Sobel, Douglas O., Joseph T. Newsome, C. Ewel, et al.. (1992). Poly I:C Induces Development of Diabetes Mellitus in BB Rat. Diabetes. 41(4). 515–520. 62 indexed citations
15.
Ewel, C., Douglas O. Sobel, Barbara J. Zeligs, & Joseph A. Bellanti. (1992). Poly I:C Accelerates Development of Diabetes Mellitus in Diabetes-Prone BB Rat. Diabetes. 41(8). 1016–1021. 65 indexed citations
16.
Urba, Walter J., C. Ewel, William Kopp, et al.. (1992). Anti-CD3 monoclonal antibody treatment of patients with CD3-negative tumors: a phase IA/B study.. PubMed. 52(9). 2394–401. 19 indexed citations
17.
Steis, Ronald G., John W. Smith, Walter J. Urba, et al.. (1991). Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.. PubMed. 77(4). 792–8. 38 indexed citations
18.
deShazo, Richard D., et al.. (1981). Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.. PubMed. 46(2). 313–20. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026